ArticlebioRxiv : the preprint server for biology2021

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice.

Jeroen Pollet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.